Right to Try Law Raises Questions About FDA, IRB Oversight: ‘IRB review may be more necessary for patient protection’

    loading  Checking for direct PDF access through Ovid

Abstract

The FDA “remains committed” to reviewing and approving investigational drugs through its expanded access program, which will continue in conjunction with the recently enacted federal Right to Try law.

Related Topics

    loading  Loading Related Articles